Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 USD | +5.35% | +4.84% | +21.12% |
May. 14 | Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.12% | 114M | |
+31.37% | 588B | |
-2.76% | 364B | |
+20.66% | 326B | |
+5.66% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.19% | 167B | |
-0.02% | 161B |
- Stock Market
- Equities
- CLRB Stock
- News Cellectar Biosciences, Inc.
- Transcript : Cellectar Biosciences, Inc. Presents at Oppenheimer 31st Annual Healthcare Conference, Mar-16-2021 08